ストックスクリーナーアプリを入手
12.53
2.19%
-0.28
アフターアワーズ：
12.55
0.02
+0.16%
Delcath Systems Inc (DCTH) 最新ニュース
Delcath Systems announces inducement grants - Medical Buyer
ETFs Investing in Delcath Systems, Inc. Stocks - TradingView
Four Delcath Employees Receive Stock Awards Tied to Vesting Dates - Stock Titan
Understanding Momentum Shifts in (DCTH) - Stock Traders Daily
Delcath Systems (DCTH) Slides 3.77% as Stock Tests Key Support LevelsFlat Correction - dars.gov.et
Is Delcath Systems Inc (DCTH) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Delcath Systems begins Phase 2 breast cancer trial - grafa.com
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - BioSpace
Delcath doses first patient in breast cancer trial in Milan By Investing.com - Investing.com Nigeria
Delcath doses first patient in breast cancer trial in Milan - Investing.com
$13.513 | Delcath Systems, Inc. Common Stock (DCTH) Stock Price Today - Binance
Delcath Systems (DCTH) Gains 2.12% as Stock Approaches Key Resistance LevelGEX Level - DonanımHaber
DCTH Q1 2026 Earnings: EPS Surprises to the Upside as Company Advances Core PipelineEarnings Per Share - dars.gov.et
DCTHDelcath Systems Inc Options - Finviz
Price to sales forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Avoiding Lag: Real-Time Signals in (DCTH) Movement - Stock Traders Daily
Delcath Systems, Inc.(NasdaqCM:DCTH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value Benchmark - marketscreener.com
Price to book forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Value-Defensive Index - marketscreener.com
Price to earnings forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Enterprise value to revenue forward of Delcath Systems, Inc. – SWB:DV3R - TradingView
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 3000 Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Delcath Systems, Inc. – NASDAQ:DCTH - TradingView
Mettler-Toledo (MTD) soars 3.3%: Is further upside left in the stock? - MSN
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2000 Defensive Index - marketscreener.com
Delcath Systems, Inc. Actuals & Estimates (FWB:DV3R) - TradingView
Delcath Systems, Inc. Actuals & Estimates (NASDAQ:DCTH) - TradingView
Delcath Systems, Inc. Actuals & Estimates (LS:A2PT5P) - TradingView
DCTH Forecast — Price Target — Prediction for 2027 - TradingView
Delcath Systems Inc (DCTH) Institutional Confidence - TradingKey
Delcath Systems (DCTH) Surges 5.6% on Above-Average Volume, Tests Key ResistanceChart Pattern Alerts - dars.gov.et
Delcath Systems, Inc. (DCTH) reports Q1 loss, misses revenue estimates - MSN
Delcath Systems Inc (DCTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Delcath Systems (DCTH) Dips 2% as Stock Approaches Critical SupportHigh Volume Stocks - dars.gov.et
Delcath Systems Inc (DCTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Delcath Systems Inc (DCTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Delcath Systems Inc (DCTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Delcath Systems Inc (DCTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Delcath Systems Inc (DCTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Delcath Systems Inc (DCTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Delcath Systems (DCTH) Rallies 3.7%—Testing Key Resistance at $12.57Covered Call Trade - dars.gov.et
Q1 2026 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems Inc (DCTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Delcath Systems (DCTH) Q1 2026 Earnings: Narrower-than-Expected Losses Amid Clinical ProgressEarnings Season Preview - dars.gov.et
Delcath Systems (DCTH) Slips 1.5% as Shares Test Critical Support Near $11NHNL Ratio - DonanımHaber
Delcath Systems, Inc. - MLQ.ai
Delcath Systems, Inc. Stock 12‑Month Price Target Cut to $20.83, Implies 95% Upside - TradingView
European cancer guidelines add Delcath liver therapy for eye melanoma - Stock Titan
Delcath therapy included in European uveal melanoma guidelines - Investing.com
FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC - Quantisnow
(DCTH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Abbott’s $21bn Bet on Exact Sciences Takes Center Stage at ASCO 2026 - Citeline News & Insights
Delcath Systems Q1 2026 Earnings: Narrowed Loss Surprises, Stock AdvancesCore Business Growth - newsline.com
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - BioSpace
Delcath Systems Publishes Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - Moomoo
Q3 2025 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Delcath Systems Inc. Q1 2026 Earnings: Narrower Loss Surprises MarketsPerformance Review - DonanımHaber
0.27%
大文字化:
|
ボリューム (24 時間):